$0.39
3.62% day before yesterday
Nasdaq, Jul 11, 10:03 pm CET
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Generation Bio Co Stock price

$0.39
-0.00 1.18% 1M
-0.53 58.00% 6M
-0.67 63.55% YTD
-2.41 86.20% 1Y
-6.36 94.28% 3Y
-17.68 97.86% 5Y
-24.30 98.44% 10Y
-24.30 98.44% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
+0.01 3.62%
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Key metrics

Basic
Market capitalization
$25.9m
Enterprise Value
$-131.7m
Net debt
positive
Cash
$157.6m
Shares outstanding
67.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 1.7
EV/Sales
negative | negative
EV/FCF
1.5
P/B
0.4
Financial Health
Equity Ratio
37.3%
Return on Equity
-152.7%
ROCE
-40.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$24.6m | $15.2m
EBITDA
$-69.2m | $-85.7m
EBIT
$-74.0m | $-71.2m
Net Income
$-71.9m | $-75.1m
Free Cash Flow
$-86.0m
Growth (TTM | estimate)
Revenue
146.3% | -23.4%
EBITDA
41.9% | -15.4%
EBIT
40.6% | 10.1%
Net Income
57.5% | 43.0%
Free Cash Flow
-31.6%
Margin (TTM | estimate)
Gross
-
EBITDA
-281.8% | -562.2%
EBIT
-301.2%
Net
-292.9% | -492.6%
Free Cash Flow
-350.0%
More
EPS
$-1.1
FCF per Share
$-1.3
Short interest
4.1%
Employees
115
Rev per Employee
$170.0k
Show more

Is Generation Bio Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Generation Bio Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Generation Bio Co forecast:

9x Buy
69%
4x Hold
31%

Analyst Opinions

13 Analysts have issued a Generation Bio Co forecast:

Buy
69%
Hold
31%

Financial data from Generation Bio Co

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
25 25
146% 146%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 36 36
25% 25%
147%
- Research and Development Expense 62 62
27% 27%
254%
-69 -69
42% 42%
-282%
- Depreciation and Amortization 4.76 4.76
9% 9%
19%
EBIT (Operating Income) EBIT -74 -74
41% 41%
-301%
Net Profit -72 -72
57% 57%
-293%

In millions USD.

Don't miss a Thing! We will send you all news about Generation Bio Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Generation Bio Co Stock News

Neutral
GlobeNewsWire
5 days ago
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the company granted equity awards to one new employee, pursuant to the company's 2025 Inducement Stock Incentive Plan, as an inducement material to such new...
Neutral
GlobeNewsWire
about 2 months ago
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D.
Neutral
GlobeNewsWire
2 months ago
-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA -  Lead target and portfolio strategy to be announced mid-2025 -  Cash balance of $157.6 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., May 07, 2025 (GLOBE NEWSWIRE) -- Generatio...
More Generation Bio Co News

Company Profile

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Head office United States
CEO Cameron McDonough
Employees 115
Founded 2016
Website generationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today